[Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization]

Rev Port Cardiol. 2001 Sep;20(9):927-8.
[Article in Portuguese]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Abciximab
  • Angioplasty, Balloon, Coronary*
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Myocardial Ischemia / prevention & control*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Tirofiban
  • Tyrosine / analogs & derivatives*
  • Tyrosine / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Tyrosine
  • Tirofiban
  • Abciximab